Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E
- PMID: 1952435
- DOI: 10.1164/ajrccm/144.5.1080
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E
Abstract
Prostaglandin E (PGE), a cyclooxygenase metabolite normally present in high concentrations in respiratory epithelial lining fluid (ELF), is capable of suppressing mesenchymal cell proliferation mediated by polypeptide-derived growth factors. Although PGE is normally abundant in respiratory ELF, PGE levels in ELF of individuals with idiopathic pulmonary fibrosis (IPF), a fibrotic lung disorder characterized by intraalveolar mesenchymal cell accumulation and fibrosis, were found to be 50% lower than normal (p less than 0.01): that is, a relative PGE "deficiency" in ELF may enhance intraalveolar mesenchymal cell proliferation in IPF. With this background, it is rational to consider augmenting PGE levels in ELF as a future therapy for IPF. Since systemic administration of PGE is associated with significant adverse effects, in vitro and experimental animal studies were carried out to evaluate whether aerosol PGE administration could augment ELF PGE levels. Greater than 50% of a solution of PGE1 could be placed in droplets less than 3 microns mass median aerodynamic diameter without loss of function. Aerosolization of PGE1 to sheep (n = 14) resulted in a marked augmentation of ELF PGE1 levels (preaerosol 20 +/- 7 nM, 30 min postaerosol 1,150 +/- 210 nM; p less than 0.0 to 0.1). ELF PGE1 levels remained elevated for up to 2 h (p less than 0.05 compared with baseline) and returned to baseline by 3 h (p greater than 0.2). Lung interstitial fluid (lymph) PGE1 levels increased slightly, but to levels far less than ELF levels (preaerosol 7 +/- 1 nM, 30 min postaerosol 13 +/- 2 nM; p less than 0.01), and plasma PGE1 levels did not change (p greater than 0.1).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.Proc Natl Acad Sci U S A. 1990 Jun;87(11):4063-7. doi: 10.1073/pnas.87.11.4063. Proc Natl Acad Sci U S A. 1990. PMID: 2349219 Free PMC article.
-
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.Am Rev Respir Dis. 1989 Feb;139(2):370-2. doi: 10.1164/ajrccm/139.2.370. Am Rev Respir Dis. 1989. PMID: 2913886
-
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.J Clin Invest. 1987 Jun;79(6):1665-73. doi: 10.1172/JCI113005. J Clin Invest. 1987. PMID: 3034979 Free PMC article.
-
Aerosolization of superoxide dismutase. Augmentation of respiratory epithelial lining fluid antioxidant screen by aerosolization of recombinant human Cu++/Zn++ superoxide dismutase.Chest. 1993 Sep;104(3):811-5. doi: 10.1378/chest.104.3.811. Chest. 1993. PMID: 8396002
-
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients: A case report.Medicine (Baltimore). 2017 Dec;96(51):e9237. doi: 10.1097/MD.0000000000009237. Medicine (Baltimore). 2017. PMID: 29390478 Free PMC article. Review.
Cited by
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis.J Clin Invest. 2023 Sep 15;133(18):e172058. doi: 10.1172/JCI172058. J Clin Invest. 2023. PMID: 37712420 Free PMC article. Review.
-
Epithelial Responses in Radiation-Induced Lung Injury (RILI) Allow Chronic Inflammation and Fibrogenesis.Radiat Res. 2023 May 1;199(5):439-451. doi: 10.1667/RADE-22-00103.1. Radiat Res. 2023. PMID: 37237442 Free PMC article.
-
Lung fibrogenic microenvironment in mouse reconstitutes human alveolar structure and lung tumor.iScience. 2022 Aug 11;25(9):104912. doi: 10.1016/j.isci.2022.104912. eCollection 2022 Sep 16. iScience. 2022. PMID: 36060050 Free PMC article.
-
KLF4 is a therapeutically tractable brake on fibroblast activation that promotes resolution of pulmonary fibrosis.JCI Insight. 2022 Aug 22;7(16):e160688. doi: 10.1172/jci.insight.160688. JCI Insight. 2022. PMID: 35852857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources